|
1
|
Maclaran K and Panay N: Current concepts
in premature ovarian insufficiency. Womens Health (Lond).
11:169–182. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
European Society for Human Reproduction
and Embryology (ESHRE) Guideline Group on POI. Webber L, Davies M,
Anderson R, Bartlett J, Braat D, Cartwright B, Cifkova R, de Muinck
Keizer-Schrama S, Hogervorst E, et al: ESHRE guideline: Management
of women with premature ovarian insufficiency. Hum Reprod.
31:926–937. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sadrzadeh S, Painter RC, van Kasteren YM,
Braat DDM and Lambalk CB: Premature ovarian insufficiency and
perinatal parameters: A retrospective case-control study.
Maturitas. 96:72–76. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Podfigurna-Stopa A, Czyzyk A, Grymowicz M,
Smolarczyk R, Katulski K, Czajkowski K and Meczekalski B: Premature
ovarian insufficiency: The context of long-term effects. J
Endocrinol Invest. 39:983–990. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sullivan SD, Sarrel PM and Nelson LM:
Hormone replacement therapy in young women with primary ovarian
insufficiency and early menopause. Fertil Steril. 106:1588–1599.
2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chi J and Zhang Y: Observations on the
efficacy of auricular pressure therapy combined with kuntai capsule
in the treatment of uterine fibroids combined with perimenopausal
syndrome. Hainan Med J. 27:3032–3034. 2016.
|
|
7
|
Xu J and Sun J: Experimental study on the
effect of prevention and treatment of Kuntai capsule on
osteoporosis in ovariectomized rats-CNKI. Mode J Inte Trad Chin
West Med. 24:2873–2875. 2015.
|
|
8
|
Zhu J and Wang X: Meta-analysis of
efficacy and safety of Kuntai capsule combined with hormone therapy
in treatment of climacteric syndrome. Chin Arch Trad Chin. 58–65.
2021.
|
|
9
|
Zhang B, Zhang L, Yang Y, Sun X, Yang L,
Wang L and Zhang X: Efficacy of Kuntai capsule for treating ovarian
reserve dysfunction: A meta-analysis. Chin J Reprod Contracep.
40:750–755. 2020.
|
|
10
|
Xu L: Clinical effect analysis of
dehydroepiandrosterone combined with Kuntai capsule in the
treatment of infertility due to hypo-ovarian reserve. Mater Child
Heal Care Chin. 35:3851–3854. 2020.
|
|
11
|
Cao H, Li H, Lin G, Li X, Liu S, Li P,
Cong C and Xu L: The clinical value of acupuncture for women with
premature ovarian insufficiency: A systematic review and
meta-analysis of randomized controlled trials. Front Endocrinol
(Lausanne). 15(1361573)2024.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Higgins JPT, Altman DG, Gøtzsche PC, Jüni
P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, et
al: The cochrane collaboration's tool for assessing risk of bias in
randomised trials. BMJ. 343(d5928)2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Moher D, Liberati A, Tetzlaff J and Altman
DG: PRISMA Group. Preferred reporting items for systematic reviews
and meta-analyses: The PRISMA statement. PLoS Med.
6(e1000097)2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Luan S, Cui Q, Zhang Y and Ma H: Clinical
efficacy of Kuntai capsule in the treatment of premature ovarian
failure. Chin Tradit Pat Med. 39:1318–1320. 2017.
|
|
15
|
Li W, An L, Zhang G, et al: The combined
application of estradiol valerate-cproterone acetate and Kuntai
capsule in poor ovarian responders of in vitro fertilization. J
Pract Obstet Gynecol. 30:681–685. 2014.
|
|
16
|
Jia X: Clinical effect of Kuntai capsule
combined with estradiol tablet/estradiol didroxyprogesterone tablet
in the treatment of infertility with low ovarian reserve function.
Pract Clin Med. 20:42–43. 2019.
|
|
17
|
Wu S: Study on the value of Kuntai and HRT
treating premature ovarian failure. Pract Gynecol Endocr.
6:114–119. 2019.
|
|
18
|
Yuan H and Hu Y: Effect of Kuntai capsule
combined with hormone replacement therapy on premature ovarian
failure. Hubei J TCM. 41:16–18. 2019.
|
|
19
|
Yuan H and Hu Y: Clinical observation of
climen combined with kuntai capsule in treatment of diminished
ovarian reserve. Hubei J TCM. 40:7–9. 2018.
|
|
20
|
Hong: Clinical study on treatment of
premature ovarian insufficiency with integrated Chinese and western
medicine (unpublished thesis). Hubei University of Traditional
Chinese Medicine, 2018.
|
|
21
|
Hu Y: The application of kuntai combined
with femoston in patients with premature ovarian insufficiency
complicated with infertility. Chin Med Mod Distance Edu China.
16:107–109. 2018.
|
|
22
|
Xiao PM, Xu YY and Shi YH: Clinical
efficacy of Climen combined with Kuntai capsule for premature
ovarian failure. Chin J Gener Pract. 13:774–775, 787. 2015.
|
|
23
|
Yao Y, Xia M, Wang C and Wan D: Clinical
observation of Kuntai capsule combined with climen in treatment of
diminished ovarian reserve. In: Proceedings of the 13th National
Conference on traditional Chinese Medicine and Gynecology, Guiyang,
pp611-612, 2013.
|
|
24
|
Torrealday S, Kodaman P and Pal L:
Premature ovarian insufficiency-an update on recent advances in
understanding and management. F1000Res. 6(2069)2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang J, Fang L, Shi L, Lai Z, Lu Z, Xiong
J, Wu M, Luo A and Wang S: Protective effects and mechanisms
investigation of Kuntai capsule on the ovarian function of a novel
model with accelerated aging ovaries. J Ethnopharmacol.
195:173–181. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang H, Qin F, Liu A, Sun Q, Wang Q, Li
Q, Lu S, Zhang D and Lu Z: Kuntai capsule attenuates premature
ovarian failure through the PI3K/AKT/mTOR pathway. J
Ethnopharmacol. 239(111885)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhou X, Wang L, Pan W and Li J: Clinical
Observation on the treatment of premature ovarian failure with
Kuntai capsule combined with hormone. J New Chin Med. 49:79–81.
2017.
|
|
28
|
Liu W, Nguyen TN, Tran Thi TV and Zhou S:
Corrigendum to ‘Kuntai capsule plus hormone therapy vs hormone
therapy alone in patients with premature ovarian failure: A
systematic review and meta-analysis’. Evid Based Complement
Alternat Med. 2021(5737914)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chen JM, Gao HY, Ding Y, Yuan X, Wang Q,
Li Q and Jiang GH: Efficacy and safety investigation of Kuntai
capsule for the add-back therapy of gonadotropin releasing hormone
agonist administration to endometriosis patients: A randomized,
double-blind, blank- and tibolone-controlled study. Chin Med J
(Engl). 128:427–432. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ma Q, Tan Y and Mo G: Effectiveness of
cotreatment with Kuntai capsule and climen for premature ovarian
failure: A meta-analysis. Evid Based Complement Alternat Med.
2020(4367359)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang X, Zhang L, Xiong L, Liu X, Zhang J,
Yu F, Li Y, Chang W and Chen W: Kuntai capsule for the treatment of
diminished ovarian reserve: A systematic review and meta-analysis
of randomized controlled trials. J Ethnopharmacol.
329(118167)2024.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Lian F and Jiang XY: Effect of kuntai
capsule on the number of retrieved oocytes, high-quality oocytes
and embryos in in vitro fertilization of poor ovarian response
patients. Zhongguo Zhong Xi Yi Jie He Za Zhi. 34:917–921.
2014.PubMed/NCBI(In Chinese).
|
|
33
|
Liu W, Nguyen TN, Tran Thi TV and Zhou S:
Kuntai capsule plus hormone therapy vs hormone therapy alone in
patients with premature ovarian failure: A systematic review and
meta-analysis. Evid Based Complement Alternat Med.
2019(2085804)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lin W, Zeng XP, Deng J, Liu Y, Cai RH,
Chen HY and Shi DH: Kuntai capsules in treatment of premature
ovarian failure: A systematic review and meta-analysis. J Herb Med.
31(100524)2022.
|
